Logo image of CORT

CORCEPT THERAPEUTICS INC (CORT) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:CORT - US2183521028 - Common Stock

45.85 USD
-0.37 (-0.8%)
Last: 1/28/2026, 8:00:01 PM
45.85 USD
0 (0%)
After Hours: 1/28/2026, 8:00:01 PM
Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to CORT. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 92.82. This target is 102.44% above the current price.
  • CORT was analyzed by 12 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CORT.
  • In the last month the buy percentage fell by 5 points. So the trust of analysts is decreasing.
  • CORT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
CORT Historical Analyst RatingsCORT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -109 -99 -89 -79 -69 -59 -49 -39 -29 -19 -9 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 45.8550.5096.9092.82127.05 - 10.14% 111.34% 102.44% 177.10%
CORT Current Analyst RatingCORT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2026-01-23 Canaccord Genuity Maintains Buy -> Buy
2026-01-23 HC Wainwright & Co. Maintains Buy -> Buy
2026-01-02 Canaccord Genuity Maintains Buy -> Buy
2026-01-02 HC Wainwright & Co. Maintains Buy -> Buy
2025-12-16 UBS Initiate Neutral
2025-11-25 HC Wainwright & Co. Reiterate Buy -> Buy
2025-11-18 Wolfe Research Initiate Peer Perform
2025-10-20 HC Wainwright & Co. Reiterate Buy -> Buy
2025-10-10 HC Wainwright & Co. Reiterate Buy -> Buy
2025-09-25 Canaccord Genuity Maintains Buy -> Buy
2025-09-10 Canaccord Genuity Maintains Buy -> Buy
2025-08-01 Canaccord Genuity Maintains Buy -> Buy
2025-08-01 Piper Sandler Maintains Overweight -> Overweight
2025-05-06 HC Wainwright & Co. Maintains Buy -> Buy
2025-04-03 Piper Sandler Maintains Overweight -> Overweight
2025-04-01 Canaccord Genuity Maintains Buy -> Buy
2025-03-31 Truist Securities Maintains Buy -> Buy
2025-03-31 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-27 Piper Sandler Maintains Overweight -> Overweight
2025-02-27 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-11 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-07 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-30 Canaccord Genuity Maintains Buy -> Buy
2024-10-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-18 HC Wainwright & Co. Maintains Buy -> Buy
2024-09-30 Truist Securities Maintains Buy -> Buy
2024-09-18 Piper Sandler Maintains Overweight -> Overweight
2024-07-31 Canaccord Genuity Maintains Buy -> Buy
2024-07-30 Canaccord Genuity Maintains Buy -> Buy
2024-07-30 Piper Sandler Maintains Overweight -> Overweight

CORCEPT THERAPEUTICS INC / CORT FAQ

What is the price target for CORT stock?

12 analysts have analysed CORT and the average price target is 92.82 USD. This implies a price increase of 102.44% is expected in the next year compared to the current price of 45.85.


How do analysts rate CORCEPT THERAPEUTICS INC (CORT)?

The consensus rating for CORCEPT THERAPEUTICS INC (CORT) is 75 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover CORCEPT THERAPEUTICS INC (CORT) stock?

The number of analysts covering CORCEPT THERAPEUTICS INC (CORT) is 12.